-
Mylan: Court upholds patents protecting Perforomist
PITTSBURGH — Mylan on Monday announced the U.S. District Court for the Northern District of West Virginia ruled in favor of upholding the validity of patents protecting Perforomist (formoterol fumarate) Inhalation Solution. Mylan previously sued Teva alleging that Teva's abbreviated new drug application for this product infringed four Mylan patents covering Perforomist.
The court's decision prevents Teva's ANDA, which has yet to receive a tentative approval from the Food and Drug Administration.
-
IMS Health to launch IPO
NEW YORK — IMS Health Holdings is expected to launch an initial public stock offering in two weeks, according to a report Sunday in the Wall Street Journal. The syndicated prescription data service could be valued as much as $7 billion, WSJ noted, citing people familiar with the matter, with a per-share price of as much as $21.